English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 12 Help

Selected(0)Clear Items/Page:    Sort:
Development of GPC3-CAR-NK cells and optimization as a therapy for HCC Journal article
Cao, Bihui, Ni, Qianqian, Chen, Zhuxin, Yang, Shuo, Zhang, Xinkui, Su, Haotao, Zheng, Zhenfeng, Zhao, Qi, Zhu, Xiaolan, Liu, Manting. Development of GPC3-CAR-NK cells and optimization as a therapy for HCC[J]. Journal of leukocyte biology, 2024, 0(0), 1-11.
Authors:  Cao, Bihui;  Ni, Qianqian;  Chen, Zhuxin;  Yang, Shuo;  Zhang, Xinkui; et al.
Favorite | TC[WOS]:0  | Submit date：2024/08/20
Hcc  Mwa  Chimeric Antigen Receptor  Glypican-3  Natural Killer.  
Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展 Journal article
Li,Shuang, Liu,Zherui, Lu,Yinying. Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展[J]. Journal of Clinical Hepatology, 2023, 39(5), 1019-1029.
Authors:  Li,Shuang;  Liu,Zherui;  Lu,Yinying
Favorite | TC[Scopus]:0 | Submit date：2023/08/03
Carcinoma, Hepatocellular  Chimeric Antigen  Receptors  T-lymphocytes  Therapeutics  
CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo Journal article
Liu, Manting, Huang, Wensou, Guo, Yongjian, Zhou, Yubo, Zhi, Cheng, Chen, Jingwu, Li, Junping, He, Jinping, Lian, Hui, Zhou, Jingwen, Ye, Xiaodie, Hu, Yuling, Hu, Hong, Liu, Zhaoyuan, Huang, Jingjun, Lin, Liteng, Cai, Mingyue, Wang, Xiaobin, Huang, Jingzhen, Zhang, Zhenfeng, Zhu, Kangshun, Zhao, Qi, Cao, Bihui. CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo[J]. Journal of Leukocyte Biology, 2022, 112(4), 901-911.
Authors:  Liu, Manting;  Huang, Wensou;  Guo, Yongjian;  Zhou, Yubo;  Zhi, Cheng; et al.
Favorite | TC[WOS]:38 TC[Scopus]:35  IF:3.6/5.2 | Submit date：2022/05/17
Chimeric Antigen Receptor  Delta-like Ligand 3  Nk-92 Cells  Sclc  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, J., Yang, S., Cao, B., Zhou , G., Zhang, F., Wang, Y., Wang, R., Zhu, L., Meng, Y., Hu, C., Liang, H., Lin, X., Zhu, K., Chen, G., Luo, K.Q., Di, L., Zhao, Q.. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology & Oncology, 2021, 14(1), 1-18.
Authors:  Liu, J.;  Yang, S.;  Cao, B.;  Zhou , G.;  Zhang, F.; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64 | Submit date：2022/08/26
B7-h3  Chimeric Antigen Receptor  Bispecific Antibody  Non-small Cell Lung  
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, Jie, Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhang, Fengjuan, Wang, Yuan, Wang, Rixin, Zhu, Lipeng, Meng, Ya, Hu, Cong, Liang, Hui, Lin, Xu, Zhu, Kangshun, Chen, Guokai, Luo, Kathy Qian, Di, Lijun, Zhao, Qi. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology and Oncology, 2021, 14(1), 1-18.
Authors:  Liu, Jie;  Yang, Shuo;  Cao, Bihui;  Zhou, Guangyu;  Zhang, Fengjuan; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64  IF:29.5/26.9 | Submit date：2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy Journal article
Zhu, Lipeng, Liu, Jie, Zhou, Guangyu, Liu, Tzu Ming, Dai, Yunlu, Nie, Guangjun, Zhao, Qi. Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy[J]. Small, 2021, 17(43), 2102624.
Authors:  Zhu, Lipeng;  Liu, Jie;  Zhou, Guangyu;  Liu, Tzu Ming;  Dai, Yunlu; et al.
Adobe PDF | Favorite | TC[WOS]:59 TC[Scopus]:62  IF:13.0/13.5 | Submit date：2021/12/08
B7-h3 Immune Checkpoint  Chimeric Antigen Receptor t Cell  Immunotherapy  Nanozyme  Photothermal-nanocatalytic Effect  
Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy Journal article
Zhu, L., Liu, J., Zhou, G., Liu, T., Dai, Y., Nie, G., Zhao, Q.. Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy[J]. Small, 2021, 2102624-2102624.
Authors:  Zhu, L.;  Liu, J.;  Zhou, G.;  Liu, T.;  Dai, Y.; et al.
Favorite |  | Submit date：2023/08/25
B7-H3 immune checkpoint  chimeric antigen receptor T cell  immunotherapy  nanozyme  photothermal-nanocatalytic effect  
Development of mesothelin-specific car nk-92 cells for the treatment of gastric cancer Journal article
Cao, Bihui, Liu, Manting, Huang, Jingjun, Zhou, Jingwen, Li, Junping, Lian, Hui, Huang, Wensou, Guo, Yongjian, Yang, Shuo, Lin, Liteng, Cai, Mingyue, Zhi, Cheng, Wu, Jingqiang, Liang, Licong, Hu, Yuling, Hu, Hong, He, Jinping, Liang, Baoxia, Zhao, Qi, Zhu, Kangshun. Development of mesothelin-specific car nk-92 cells for the treatment of gastric cancer[J]. International Journal of Biological Sciences, 2021, 17(14), 3850-3861.
Authors:  Cao, Bihui;  Liu, Manting;  Huang, Jingjun;  Zhou, Jingwen;  Li, Junping; et al.
Favorite | TC[WOS]:50 TC[Scopus]:46  IF:8.2/8.3 | Submit date：2022/05/13
Chimeric Antigen Receptor  Gastric Cancer  Mesothelin  Nk-92  Pdx  
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer Journal article
Yang,Shuo, Cao,Bihui, Zhou,Guangyu, Zhu,Lipeng, Wang,Lu, Zhang,Li, Kwok,Hang Fai, Zhang,Zhenfeng, Zhao,Qi. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer[J]. Frontiers in Pharmacology, 2020, 11, 1089.
Authors:  Yang,Shuo;  Cao,Bihui;  Zhou,Guangyu;  Zhu,Lipeng;  Wang,Lu; et al.
Favorite | TC[WOS]:45 TC[Scopus]:48  IF:4.4/5.0 | Submit date：2021/03/04
B7-h3  Chimeric Antigen Receptor  Immune Checkpoint  Natural Killer Cell  Nk-92  
Building potent chimeric antigen receptor T cells with CRISPR genome editing Journal article
Liu, J., Zhou, G., Zhang, L., Zhao, Q.. Building potent chimeric antigen receptor T cells with CRISPR genome editing[J]. Frontiers in Immunology, 2019, 456-456.
Authors:  Liu, J.;  Zhou, G.;  Zhang, L.;  Zhao, Q.
Favorite |   IF:5.7/6.8 | Submit date：2023/08/25
chimeric antigen receptor  CRISPR  gene editing  immunotherapy  cancer  CAR T